| Literature DB >> 35112763 |
Zeinab Mohseni Afshar1, Mohammad Barary2,3, Arefeh Babazadeh4, Rezvan Hosseinzadeh2, Amirmasoud Alijanpour5, Seyed Rouhollah Miri6, Terence T Sio7, Mark J M Sullman8,9, Kristin Carson-Chahhoud10, Florian Langer11, Soheil Ebrahimpour4.
Abstract
Since the start of the pandemic, thrombotic events have been a well-known and severe complication associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Nevertheless, the initiation of vaccination programs brought another rare yet highly fatal thrombotic event, vaccine-induced immune thrombotic thrombocytopaenia, which has caused extensive debate regarding the safety of vaccines. This review defines the thromboembolic events following infection and vaccination, identifies their risk factors, describes their pathophysiology, and discusses their management, treatment, and prevention.Entities:
Keywords: Covid-19; SARS-CoV-2; VITT; thrombosis
Mesh：
Substances：
Year: 2022 PMID： 35112763 DOI： 10.1002/rmv.2327
Source DB: PubMed Journal: Rev Med Virol ISSN： 1052-9276 Impact factor: 11.043